Literature DB >> 11307744

Passive respiratory mechanics: the occlusion techniques.

M Gappa1, A A Colin, I Goetz, J Stocks.   

Abstract

The aim of this position paper is to define quality control and acceptance criteria for measuring passive respiratory mechanics in infants using the occlusion techniques to ensure that valid results are obtained. These guidelines cover numerous aspects including: 1) terminology and definitions; 2) equipment; 3) data acquisition; 4) data handling and analysis; 5) reporting of results. Adherence to these guidelines should ensure that measurement of passive respiratory mechanics in infants in different lung function laboratories could be performed with an acceptable degree of safety, precision, and reproducibility. This will facilitate multi-centre collection of data and performance of clinical investigations.

Entities:  

Mesh:

Year:  2001        PMID: 11307744     DOI: 10.1183/09031936.01.17101410

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Diagnosis of asthma.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

2.  Respiratory Compliance in Late Preterm Infants (340/7-346/7 Weeks) after Antenatal Steroid Therapy.

Authors:  Mitzi Go; Diane Schilling; Thuan Nguyen; Manuel Durand; Cindy T McEvoy
Journal:  J Pediatr       Date:  2018-06-25       Impact factor: 4.406

3.  Respiratory function in healthy late preterm infants delivered at 33-36 weeks of gestation.

Authors:  Cindy McEvoy; Sridevi Venigalla; Diane Schilling; Nakia Clay; Patricia Spitale; Thuan Nguyen
Journal:  J Pediatr       Date:  2012-11-06       Impact factor: 4.406

4.  Does decline of lung function in wheezy infants justify the early start of controller medications?

Authors:  Magdy Zedan; Nehad Nasef; Mohamed El-Bayoumy; Mohamed El-Assmy; Gehan Attia; Mohamed Zedan; Angi AlWakeel; Shaimaa Kandil; Wafaa Laimon; Ashraf Fouda
Journal:  Indian J Pediatr       Date:  2012-09       Impact factor: 1.967

5.  Response to bronchodilators in very preterm infants with evolving bronchopulmonary dysplasia.

Authors:  Daniel K Morrow; Diane Schilling; Cindy T McEvoy
Journal:  Res Rep Neonatol       Date:  2015-12-02

6.  The Effect of Extended Continuous Positive Airway Pressure on Changes in Lung Volumes in Stable Premature Infants: A Randomized Controlled Trial.

Authors:  Ryan Lam; Diane Schilling; Brian Scottoline; Astrid Platteau; Meike Niederhausen; Kelli C Lund; Robert L Schelonka; Kelvin D MacDonald; Cindy T McEvoy
Journal:  J Pediatr       Date:  2019-09-10       Impact factor: 4.406

7.  Pulmonary Function at Hospital Discharge in Preterm Infants Randomized to a Single Rescue Course of Antenatal Steroids.

Authors:  Brian K Jordan; Diane Schilling; Cindy T McEvoy
Journal:  J Pediatr       Date:  2016-11-07       Impact factor: 4.406

8.  Pulmonary function and outcomes in infants randomized to a rescue course of antenatal steroids.

Authors:  Cindy McEvoy; Diane Schilling; Patricia Spitale; Jean O'Malley; Susan Bowling; Manuel Durand
Journal:  Pediatr Pulmonol       Date:  2017-04-24

Review 9.  An Official American Thoracic Society/European Respiratory Society Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units.

Authors:  Stacey Peterson-Carmichael; Paul C Seddon; Ira M Cheifetz; Inéz Frerichs; Graham L Hall; Jürg Hammer; Zoltán Hantos; Anton H van Kaam; Cindy T McEvoy; Christopher J L Newth; J Jane Pillow; Gerrard F Rafferty; Margaret Rosenfeld; Janet Stocks; Sarath C Ranganathan
Journal:  Ann Am Thorac Soc       Date:  2016-02

10.  Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial.

Authors:  Cindy T McEvoy; Diane Schilling; Nakia Clay; Keith Jackson; Mitzi D Go; Patricia Spitale; Carol Bunten; Maria Leiva; David Gonzales; Julie Hollister-Smith; Manuel Durand; Balz Frei; A Sonia Buist; Dawn Peters; Cynthia D Morris; Eliot R Spindel
Journal:  JAMA       Date:  2014-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.